Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.275,56
-1,38%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada NEO Abbvie CDR (ABBV) Abbvie CDR (ABBV) Notizie

Abbvie CDR

ABBV
26,52
1,14 (4,49%)
31 Gen 2025 - Chiuso
Dati in Tempo Reale
Borsa: NEO
Tipo: Ricevuta di Deposito
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
31/1/202513:42EDGAR2Form 8-K - Current report
31/1/202513:36PRNUSAbbVie Reports Full-Year and Fourth-Quarter 2024 Financial..
29/1/202510:00PRNUSAllergan Aesthetics launches new AA Signature Program at..
24/1/202510:00PRNUSAllergan Aesthetics unveils new AA Signature Program and..
23/1/202515:16PRNUSAbbVie Completes Acquisition of Nimble Therapeutics
23/1/202515:00PRNUSAbbVie and Neomorph Announce Collaboration to Develop..
13/1/202515:00PRNUSAbbVie and Simcere Zaiming Announce Partnership to Develop a..
13/1/202514:31PRNUSAbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314..
10/1/202514:31EDGAR2Form 8-K - Current report
09/1/202514:00PRNUSAbbVie to Present at the 43rd Annual J.P. Morgan Healthcare..
07/1/202514:00PRNUSCoolMonth is Back With Deals on CoolSculpting® Elite by..
06/1/202522:02EDGAR2Form 8-K - Current report
03/1/202514:00PRNUSAbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings..
19/12/202414:00PRNCAAbbVie's atogepant and onabotulinumtoxinA receive strong..
18/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202423:34EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:05EDGAR2Form 8-K - Current report
13/12/202415:15PRNUSAbbVie to Acquire Nimble Therapeutics, Further Strengthening..
11/12/202415:15PRNUSAbbVie Completes Acquisition of Aliada Therapeutics
09/12/202418:00PRNUSTwo Data Analyses From Clinical Trials Show Epcoritamab..
09/12/202414:00PRNUSAbbVie Announces Positive Topline Results for the Phase 3..
08/12/202421:00PRNUSAbbVie Announces Emotional Impact Report on Mental Health of..
08/12/202401:00PRNUSInvestigational Epcoritamab (DuoBody® CD3xCD20) Combination..
25/11/202414:00PRNUSAbbVie to Present at Citi's 2024 Global Healthcare..
18/11/202415:00PRNUSAllergan Aesthetics Offers Free Business Education Courses..
18/11/202407:00PRNUSAbbVie Receives European Commission Approval of ELAHERE®..
14/11/202414:15PRNUSAbbVie Awards 20 Individuals Living With Migraine To Support..
11/11/202414:30PRNUSAbbVie Provides Update on Phase 2 Results for Emraclidine in..
07/11/202414:00PRNUSAllergan Aesthetics Celebrates Annual BOTOX® Cosmetic..
04/11/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202420:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202411:55IHMARKETNEWSAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising..
31/10/202413:00GLOBEAbbVie and EvolveImmune Therapeutics Announce Collaboration..
31/10/202413:00PRNUSAbbVie and EvolveImmune Therapeutics Announce Collaboration..
30/10/202412:43EDGAR2Form 8-K - Current report
30/10/202412:38PRNUSAbbVie Reports Third-Quarter 2024 Financial Results
29/10/202413:00PRNUSSkinSpirit joins Allergan Aesthetics in Supporting Girls..
28/10/202413:00PRNUSAbbVie to Acquire Aliada Therapeutics, Strengthening Focus..
24/10/202417:30PRNUSAbbVie and Gedeon Richter Announce New Collaboration for the..
21/10/202414:00PRNCANine Provinces Approve Accelerated Public Reimbursement of..
19/10/202401:44PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval..
17/10/202414:00PRNUSU.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for..
16/10/202414:00PRNUSAllergan Aesthetics to Present New Data at 2024 American..
04/10/202415:00PRNUSAllergan Aesthetics and Girls Inc. Celebrate Six Years and..
03/10/202422:07EDGAR2Form 8-K - Current report
02/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202415:00IHNWTransforming Alzheimer's Treatment: Innovative Combinations..
02/10/202414:00PRNUSAvailable Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to..
01/10/202414:00PRNUSAbbVie to Host Third-Quarter 2024 Earnings Conference Call
Apertura: 26,88 Min: 26,52 Max: 27,54
Chiusura: 25,38

La tua Cronologia

NEO
ABBV
Abbvie CDR
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci